Alzheimer's disease is one of the most commonly diagnosed cases of senile dementia in the
world. It is an incurable process, most often leading to death. This disease is multifactorial …

As the population ages, Alzheimer's disease (AD), the most common neurodegenerative
disease in elderly people, will impose social and economic burdens to the world. Currently …

Alzheimer's disease (AD), the most common form of dementia, has increasing incidence,
increasing mortality rates, and poses a huge burden on healthcare. None of the currently …

Neurodegenerative diseases represent a growing burden on healthcare systems worldwide.
Mesenchymal stem cells (MSCs) have shown promise as a potential therapy due to their …

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation is a
promising therapy for Alzheimer's disease (AD). However, hUC-MSCs cultured in vitro easily …

Alzheimer's disease (AD) is a common neurodegenerative disease that contributes to 60–
70% of dementia in elderly people and is currently incurable. Current treatments only relieve …

Abstract Hypothesis We hypothesized that Lomecel‐B, an allogeneic medicinal signaling
cell (MSC) therapeutic candidate for Alzheimer's disease (AD), is safe and potentially …

Alzheimer's disease (AD) is a neurodegenerative disorder. The pathology of AD is
characterized by extracellular amyloid beta (Aβ) plaques, neurofibrillary tangles composed …

The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates
neuropathology and improves cognitive deficits in animal models with Alzheimer's disease …

Aim This article aims to study the benefits and disadvantages of stem cell therapy, especially
for patients who have dementia. Methods The databases PubMed, Google Scholar, and the …